Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Bartonella quintana RNA pyrophosphohydrolase (rppH) CSB-YP763821BSH
CSB-EP763821BSH
CSB-BP763821BSH
CSB-MP763821BSH
CSB-EP763821BSH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bartonella quintana 3-phosphoshikimate 1-carboxyvinyltransferase (aroA) CSB-YP763822BSH
CSB-EP763822BSH
CSB-BP763822BSH
CSB-MP763822BSH
CSB-EP763822BSH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bartonella quintana UDP-N-acetylenolpyruvoylglucosamine reductase (murB) CSB-YP763823BSH
CSB-EP763823BSH
CSB-BP763823BSH
CSB-MP763823BSH
CSB-EP763823BSH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bartonella quintana Putative ABC transporter ATP-binding protein BQ02700 (BQ02700) CSB-YP763824BSH
CSB-EP763824BSH
CSB-BP763824BSH
CSB-MP763824BSH
CSB-EP763824BSH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bartonella quintana 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (dapD) CSB-YP763825BSH
CSB-EP763825BSH
CSB-BP763825BSH
CSB-MP763825BSH
CSB-EP763825BSH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bartonella quintana 50S ribosomal protein L35 (rpmI) CSB-YP763826BSH
CSB-EP763826BSH
CSB-BP763826BSH
CSB-MP763826BSH
CSB-EP763826BSH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bartonella quintana Succinyl-diaminopimelate desuccinylase (dapE) CSB-YP763827BSH
CSB-EP763827BSH
CSB-BP763827BSH
CSB-MP763827BSH
CSB-EP763827BSH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bartonella quintana Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase (lpxA) CSB-YP763828BSH
CSB-EP763828BSH
CSB-BP763828BSH
CSB-MP763828BSH
CSB-EP763828BSH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bartonella henselae Acetyl-coenzyme A synthetase (acsA), partial CSB-YP763829BSG
CSB-EP763829BSG
CSB-BP763829BSG
CSB-MP763829BSG
CSB-EP763829BSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bartonella henselae 50S ribosomal protein L32 (rpmF) CSB-YP763830BSG
CSB-EP763830BSG
CSB-BP763830BSG
CSB-MP763830BSG
CSB-EP763830BSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bartonella henselae Maf-like protein BH14130 (BH14130) CSB-YP763831BSG
CSB-EP763831BSG
CSB-BP763831BSG
CSB-MP763831BSG
CSB-EP763831BSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bartonella henselae 50S ribosomal protein L34 (rpmH) CSB-YP763832BSG
CSB-EP763832BSG
CSB-BP763832BSG
CSB-MP763832BSG
CSB-EP763832BSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bartonella henselae 50S ribosomal protein L25 (rplY) CSB-YP763833BSG
CSB-EP763833BSG
CSB-BP763833BSG
CSB-MP763833BSG
CSB-EP763833BSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bartonella henselae Ribosomal RNA small subunit methyltransferase H (rsmH) CSB-YP763834BSG
CSB-EP763834BSG
CSB-BP763834BSG
CSB-MP763834BSG
CSB-EP763834BSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bartonella henselae UDP-N-acetylenolpyruvoylglucosamine reductase (murB) CSB-YP763835BSG
CSB-EP763835BSG
CSB-BP763835BSG
CSB-MP763835BSG
CSB-EP763835BSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bartonella henselae 30S ribosomal protein S10 (rpsJ) CSB-YP763836BSG
CSB-EP763836BSG
CSB-BP763836BSG
CSB-MP763836BSG
CSB-EP763836BSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bartonella henselae 50S ribosomal protein L22 (rplV) CSB-YP763837BSG
CSB-EP763837BSG
CSB-BP763837BSG
CSB-MP763837BSG
CSB-EP763837BSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bartonella henselae 30S ribosomal protein S13 (rpsM) CSB-YP763838BSG
CSB-EP763838BSG
CSB-BP763838BSG
CSB-MP763838BSG
CSB-EP763838BSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bartonella henselae Phosphopantetheine adenylyltransferase (coaD) CSB-YP763839BSG
CSB-EP763839BSG
CSB-BP763839BSG
CSB-MP763839BSG
CSB-EP763839BSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bartonella henselae Polyphosphate kinase (ppk), partial CSB-YP763840BSG
CSB-EP763840BSG
CSB-BP763840BSG
CSB-MP763840BSG
CSB-EP763840BSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>